Evidence map›Paper›PMID 28589454›Full record

ArticleDrug delivery and translational research2018

Synthesis, physico-chemical characterization, and antioxidant effect of PEGylated cerium oxide nanoparticles.

Yingfei Xue, Sricharani Rao Balmuri, Akhil Patel, Vinayak Sant, Shilpa Sant

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Pegylated nanoceria: A versatile nanomaterial for noninvasive treatment of retinal diseases.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Novel drug delivery systems, devices, and fabrication methods.Drug delivery and translational research · 2018
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yingfei XueDepartment of Pharmaceutical Sciences, University of Pittsburgh, 808A Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Sricharani Rao BalmuriDepartment of Pharmaceutical Sciences, University of Pittsburgh, 808A Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Akhil PatelDepartment of Pharmaceutical Sciences, University of Pittsburgh, 808A Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Vinayak SantDepartment of Pharmaceutical Sciences, University of Pittsburgh, 808A Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA.
Shilpa SantDepartment of Pharmaceutical Sciences, University of Pittsburgh, 808A Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261, USA. shs149@pitt.edu.ORCID 0000-0002-2017-9584
University of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerium oxide nanoparticles (CNPs) represent a promising class of antioxidant nanoparticles with potential therapeutic value. Due to the easily reversible oxidation states of cerium (Ce

Indexed as

AntioxidantsCeriumNanoparticlesPolyethylene GlycolsA549 CellsAdsorptionBlood ProteinsHumansMicroscopy, Electron, TransmissionParticle SizeReactive Oxygen SpeciesSurface PropertiesAntioxidantsBlood Proteinsceric oxideCeriumPolyethylene GlycolsReactive Oxygen SpeciesAntioxidantPEGylated cerium oxide nanoparticlePolyethylene glycol (PEG)Reactive oxygen species (ROS)Shape-specific cerium oxide nanoparticles

Identifiers

PMID28589454
OpenAlexW2623273523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.